Related references
Note: Only part of the references are listed.Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial
Howard West et al.
LANCET ONCOLOGY (2019)
Systemic Inflammation in Metabolic Syndrome: Increased Platelet and Leukocyte Activation, and Key Role of CX3CL1/CX3CR1 and CCL2/CCR2 Axes in Arterial Platelet-Proinflammatory Monocyte Adhesion
Patrice Marques et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer
M. D. Hellmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Circulating Cytokines Predict Immune-Related Toxicity in Melanoma Patients Receiving Anti-PD-1-Based Immunotherapy
Su Y. Lim et al.
CLINICAL CANCER RESEARCH (2019)
Profiling Preexisting Antibodies in Patients Treated With Anti-PD-1 Therapy for Advanced Non-Small Cell Lung Cancer
Yukihiro Toi et al.
JAMA ONCOLOGY (2019)
Inverse Association Between Circulating Monocyte-Platelet Complexes and Inflammation in Ulcerative Colitis PatientsMonocyte-
Carlos Zamora et al.
INFLAMMATORY BOWEL DISEASES (2018)
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non-Small Cell Lung Cancer
Koji Haratani et al.
JAMA ONCOLOGY (2018)
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer
L. Paz-Ares et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Importance of endoscopic and histological evaluation in the management of immune checkpoint inhibitor-induced colitis
Hamzah Abu-Sbeih et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Immune-related adverse events are linked with improved progression-free survival in patients receiving anti-PD-1/PD-L1 therapy
Hammad Shafqat et al.
SEMINARS IN ONCOLOGY (2018)
Diverse types of dermatologic toxicities from immune checkpoint blockade therapy
Jonathan L. Curry et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2017)
Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy
Jarushka Naidoo et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Binding of Platelets to Lymphocytes: A Potential Anti-Inflammatory Therapy in Rheumatoid Arthritis
Carlos Zamora et al.
JOURNAL OF IMMUNOLOGY (2017)
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
Achim Rittmeyer et al.
LANCET (2017)
Platelets subvert T cell immunity against cancer via GARP-TGFβ axis
Saleh Rachidi et al.
SCIENCE IMMUNOLOGY (2017)
Platelets in cancer metastasis: To help the villain to do evil
Nailin Li
INTERNATIONAL JOURNAL OF CANCER (2016)
Platelet microparticles inhibit IL-17 production by regulatory T cells through P-selectin
Sip Dinkla et al.
BLOOD (2016)
Platelets Play Differential Role During the Initiation and Progression of Autoimmune Neuroinflammation
Sarah C. Starossom et al.
CIRCULATION RESEARCH (2015)
Metastasis-promoting role of extravasated platelet activation in tumor
Tomoharu Miyashita et al.
JOURNAL OF SURGICAL RESEARCH (2015)
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
Julie Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Immune Checkpoint Blockade
Jarushka Naidoo et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2014)
Platelets induce a proinflammatory phenotype in monocytes via the CD147 pathway in rheumatoid arthritis
Meng-yao Rong et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Cytokine Secretion from Human Monocytes Potentiated by P-Selectin-Mediated Cell Adhesion
Junsuke Suzuki et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2013)
Endocrine Side Effects Induced by Immune Checkpoint Inhibitors
Salvatore Maria Corsello et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Functional consequences of platelet binding to T lymphocytes in inflammation
Carlos Zamora et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis
Myriam Labelle et al.
CANCER CELL (2011)
Evaluation of serum IL-17 levels during ipilimumab therapy: Correlation with colitis.
M. K. Callahan et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Modulation of Natural Killer Cell Anti-Tumor Reactivity by Platelets
Theresa Placke et al.
JOURNAL OF INNATE IMMUNITY (2011)
Update on Immunologic Therapy With Anti-CTLA-4 Antibodies in Melanoma: Identification of Clinical and Biological Response Patterns, Immune-Related Adverse Events, and Their Management
Katharina C. Kaehler et al.
SEMINARS IN ONCOLOGY (2010)
Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases
Janine M. van Gils et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Circulating platelet-leukocyte aggregates: A marker of microvascular injury in diabetic patients
I. Etalamy et al.
THROMBOSIS RESEARCH (2008)
Platelet-lymphocyte conjugation differs between lymphocyte subpopulations
N Li et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Tumor antigen-specific T helper cells in cancer immunity and immunotherapy
KL Knutson et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Platelet factor 4 differentially modulates CD4+CD25+ (regulatory) versus CD4+CD25- (nonregulatory) T cells
CY Liu et al.
JOURNAL OF IMMUNOLOGY (2005)
Share Paper
